Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Durvalumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Lexington, Kentucky
This trial has two parts: in the first, doses of a new cancer drug are tested to see how well they work, and in the second, the most effective dose is given to a larger group to see how the body processes it.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.